Genemed Synthesis Inc (GSI) was established in 1994 in San Francisco to offer quality services in the area of custom peptides, custom antibodies, and custom Oligo (DNA) synthesis. In the early 1990s, there were not too many commercial companies offering such services. Synthesis of peptides and antibodies, cloning and expression of genes was worth researcher’s own time and often resulted into high quality publications. Most universities and institutions operated their own in-house core facilities to meet the demands of their scientists. Therefore, in the early phases of sub-contracting of scientific experiments and research projects, it was more about earning the trust of scientific community than the actual sub-contracting expenses. Genemed Synthesis Inc (GSI) was not only one of the selected few companies who ventured early into the commercialization of custom peptide, antibodies, and oligo (DNA) synthesis but it continued to offer better product and services through innovations and the use of latest instruments. As a result, GSI has been able to offer better quality at reduced prices and quicker turn around time. GSI can now make peptides up to ~100 amino acids perform many complex peptide modifications. Oligo (20-50 bases) can be made, quality tested and shipped within 24-hrs. Using more sophisticated DNA synthesizers and sequencers, GSI can synthesize genes up to 1-2 kb and verify by DNA sequencing. It is often quicker and less expansive to synthesize short genes than to clone them. Synthetic genes can also be cloned, expressed, and recombinant proteins purified for a variety of uses including antibody production. More than a decade of dedicated services, Genemed Synthesis Inc (GSI) is really honored to earn the trust of 1000s of scientists all over the world. They take pride in 1000s of top-quality publications from the use of their products and services. When asked about GSI’s expertise references, they simply refer to the growing list of publications instead of relying upon so called testimonials or statements from unknown users.